Form 4: Onto Innovation CFO Sells 1,100 Shares Under 10b5-1 Trading Plan

Onto Innovation's Chief Financial Officer, Mark Slicer, sold 1,100 shares of common stock at $160.41 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Mark Slicer, the Chief Financial Officer of Onto Innovation Inc., sold 1,100 shares of the company's common stock on November 15, 2024.
• The sale was executed at a price of $160.41 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan that Slicer adopted on August 16, 2024.
• Following the sale, Slicer directly owns 10,933 shares of Onto Innovation stock.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of an insider stock sale, which is common in publicly traded companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent material non-public information.

Comparison to Industry Standards

• Insider sales are a common occurrence in publicly traded companies, and the use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
• Many executives at comparable companies such as Applied Materials, Lam Research, and ASML also utilize 10b5-1 plans for their stock transactions.
• The volume of shares sold is relatively small compared to the total outstanding shares of Onto Innovation, suggesting it is a routine transaction.

Stakeholder Impact

• The sale of shares by a company executive may be perceived negatively by some shareholders, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Onto Innovation, Mark Slicer, stock sale, Rule 10b5-1, CFO, insider trading, share transaction